Arni Kristinsson

Prevention of coronary and stroke events with atorvastatin in hypertensive patients who have average or lower-than-average cholesterol concentrations, in the Anglo-Scandinavian Cardiac Outcomes Trial—Lipid Lowering Arm (ASCOT-LLA): a multicentre randomised controlled trial

Peter Sever, Björn Dahlöf, Neil R Poulter et al. · The Lancet · 2003 · 3.8K citations

Medicine, Cardiology, Pharmacotherapy +14

Prevention of cardiovascular events with an antihypertensive regimen of amlodipine adding perindopril as required versus atenolol adding bendroflumethiazide as required, in the Anglo-Scandinavian Cardiac Outcomes Trial-Blood Pressure Lowering Arm (ASCOT-BPLA): a multicentre randomised controlled trial

Björn Dahlöf, Peter Sever, Neil R Poulter et al. · The Lancet · 2005 · 2.9K citations

Medicine, Cardiology, Pharmacology +10

Mutations in the Gene for Cardiac Myosin-Binding Protein C and Late-Onset Familial Hypertrophic Cardiomyopathy

Hideshi Niimura, Linda L. Bachinski, Somkiat Sangwatanaroj et al. · New England Journal of Medicine · 1998 · 759 citations · Full text

Medicine, Genetics, Molecular Genetics +9

Prevention of Coronary and Stroke Events with Atorvastatin in Hypertensive Patients who have Average or Lower-than-Average Cholesterol Concentrations, in the Anglo-Scandinavian Cardiac Outcomes Trial???Lipid Lowering Arm (ASCOT-LLA)

Peter Sever, Neil R Poulter, Hans Wedel et al. · Drugs · 2004 · 524 citations

Medicine, Cardiology, Pharmacotherapy +16

Reduction in Cardiovascular Events With Atorvastatin in 2,532 Patients With Type 2 Diabetes

Peter Sever, Neil R Poulter, Björn Dahlöf et al. · Diabetes Care · 2005 · 394 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +17